Effects of Selenium treatment on cardiac function in Chagas heart disease: Results from the STCC randomized Trial

BACKGROUND: Chagas disease (caused by Trypanosoma cruzi infection) evolves to chronic chagasic cardiomyopathy (CCC) affecting 1.8 million people worldwide. This is the first randomized, placebo-controlled, double-blinded, clinical trial designed to estimate efficacy and safety of selenium (Se) treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Holanda, Marcelo T., Mediano, Mauro F.F., Hasslocher-Moreno, Alejandro M., Gonzaga, Beatriz M.S., Carvalho, Anna Cristina C., Ferreira, Roberto R., Garzoni, Luciana R., Pereira-Silva, Fernanda S., Pimentel, Luis O., Mendes, Marcelo O., Azevedo, Marcos J., Britto, Constança, Moreira, Otacilio C., Fernandes, Alice G., Santos, Carolina M., Constermani, Jéssica, Paravidino, Vitor B., Maciel, Erica R., Carneiro, Fernanda M., Xavier, Sérgio S., Sperandio da Silva, Gilberto M., Santos, Priscila F., Veloso, Henrique H., Brasil, Pedro E.A.A., de Sousa, Andrea S., Bonecini-de-Almeida, Maria G., da Silva, Paula S., Sangenis, Luiz Henrique C., Saraiva, Roberto M., Araujo-Jorge, Tania C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406152/
https://www.ncbi.nlm.nih.gov/pubmed/34485877
http://dx.doi.org/10.1016/j.eclinm.2021.101105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406152/
https://www.ncbi.nlm.nih.gov/pubmed/34485877
http://dx.doi.org/10.1016/j.eclinm.2021.101105

Ejemplares similares